Home > Insider Trading > Filing (0001123292-18-000752)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881524	Vivus Inc	VVUS	Pharmaceutical Preparations (2834)	943136179

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1738557	P. John Amos	C/O Vivus, Inc. 900 E. Hamilton Ave., Suite 550 Campbell CA 95008	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-18	270,000	$0.77	1,710,000	No	4	P	Direct
Common Stock	Disposition	2018-05-18	1,500	$0.77	1,708,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct

Footnotes

This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.7581 to $0.7784. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
The reporting person's sale of VIVUS common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,500 shares, with the reporting person's purchase of 555 shares of VIVUS common stock at a price of $0.4841 per share on May 11, 2018, 100 shares of VIVUS common stock at a price of $0.4991 per share on May 11, 2018 and 845 shares of VIVUS common stock at a price of $0.4997 per share on May 11, 2018. The reporting person has paid to VIVUS $415.37, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.